Why biomarkers matter
Chronological age tells you when you were born. Biological age tells you how your body is functioning. The gap between the two is measurable, and it is modifiable.
Advanced blood diagnostics can now quantify systemic inflammation, oxidative stress, hormonal balance, metabolic efficiency, and immune function with high precision. These markers form the foundation of any evidence-based longevity programme.
Key markers to track
High-sensitivity C-reactive protein (hs-CRP) measures systemic inflammation. Interleukin-6 (IL-6) tracks chronic inflammatory signalling. Lipoprotein(a) quantifies inherited cardiovascular risk. Homocysteine reflects methylation efficiency. Telomere length provides a proxy for cellular ageing. No single marker is definitive; the pattern across multiple markers reveals the full picture.
From data to action
At Elysium, the diagnostic panel is not an end in itself. Every result maps to a clinical decision: which apheresis modality, which IV protocol, which lifestyle intervention. Biotracking over time confirms whether the programme is working and where adjustments are needed.
Measure. Intervene. Measure again. That is the method.
The Elysium-König diagnostic panel was developed specifically to bridge the gap between laboratory data and clinical action in the context of apheresis and longevity medicine.
